| Gene symbol | VEGFA | Synonyms | L-VEGF, MVCD1, VEGF, VPF | Type of gene | protein-coding |
| Chromosome | 6 | Map location | 6p21.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | vascular endothelial growth factor A | ||||
| GTO ID | GTC3741 |
| Trial ID | NCT06237777 |
| Disease | Diabetic Macular Edema |
| Altered gene | VEGFA |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | SKG0106 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | An Open, Dose-escalation Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients in China |
| Year | 2024 |
| Country | China |
| Company sponsor | Wang Min |
| Other ID(s) | SKG0106-002 |
| Vector information | |||||||||
|
|||||||||
| Cohort 1 | |||||||||
|
|||||||||